| Financial Year |
March 31 2023 |
| Monetary Funds |
1,048,513,864.97 |
| Held-for-trading Financial Assets |
40,537,777.78 |
| Notes Receivable |
344,177,949.30 |
| Accounts Receivable |
1,118,287,241.22 |
| Advances to Suppliers |
64,301,603.70 |
| Other Receivables |
13,790,926.28 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
421,727,980.17 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
177,400,071.76 |
| Total Current Assets |
3,316,045,831.90 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
171,506,903.78 |
| Investment Properties |
1,631,400.00 |
| Fixed Assetes |
771,309,350.38 |
| Under-construction Projects |
310,417,309.25 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
239,969,769.16 |
| R&D expenses |
-- |
| Goodwill |
46,242,104.63 |
| Long-Term Deferred and Prepaid Expenses |
8,975,156.48 |
| Deferred Income Tax Assets |
42,099,698.89 |
| Other Non-Current Assets |
71,189,485.79 |
| Sub-Total of Non-Current Assets |
1,723,121,386.84 |
| Total Assets |
5,039,167,218.74 |
| Short-Term Loans |
123,068,012.26 |
| Trading Financial liabilities |
-- |
| Notes Payable |
650,741,427.10 |
| Accounts Payable |
291,793,686.68 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
25,697,159.24 |
| Taxes Payable |
34,311,447.00 |
| Interest Payable |
1,787,540.00 |
| Dividend Payable |
-- |
| Other payables |
102,244,878.15 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
32,162,256.28 |
| Other Current Liabilities |
100,690,150.10 |
| Sub-Total of Current Liabilities |
1,402,060,231.59 |
| Long-term Loans |
123,180,823.06 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
16,336,957.86 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
224,008,529.04 |
| Total Liabilities |
1,626,068,760.63 |
| Paid-In Capital(Or Share Stock) |
759,047,776.00 |
| Capital Surplus |
1,215,415,595.03 |
| Surplus Reserve |
95,009,562.64 |
| LESS:Treasury Stock |
51,711,949.03 |
| Undistributed Profits |
1,001,270,892.01 |
| Minority Stockholder's Interest |
384,783,985.87 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,028,314,472.24 |
| Owner's Equity（Stockholder's Equity） |
3,413,098,458.11 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,039,167,218.74 |
